Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice

Nataraj Jagadeesan,G. Chuli Roules,Devaraj V. Chandrashekar,Joshua Yang,Sanjana Kolluru,Rachita K. Sumbria
DOI: https://doi.org/10.1186/s12967-024-05008-x
IF: 8.44
2024-03-20
Journal of Translational Medicine
Abstract:Biologic TNF-α inhibitors (bTNFIs) can block cerebral TNF-α in Alzheimer's disease (AD) if these macromolecules can cross the blood–brain barrier (BBB). Thus, a model bTNFI, the extracellular domain of type II TNF-α receptor (TNFR), which can bind to and sequester TNF-α, was fused with a mouse transferrin receptor antibody (TfRMAb) to enable brain delivery via BBB TfR-mediated transcytosis. Previously, we found TfRMAb-TNFR to be protective in a mouse model of amyloidosis (APP/PS1) and tauopathy (PS19), and herein we investigated its effects in mice that combine both amyloidosis and tauopathy (3xTg-AD).
medicine, research & experimental
What problem does this paper attempt to address?